Keros Therapeutics Files 8-K
Ticker: KROS · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1664710
| Field | Detail |
|---|---|
| Company | Keros Therapeutics, Inc. (KROS) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K, pharmaceutical
TL;DR
Keros Therapeutics filed an 8-K on 3/31/25, standard corporate update.
AI Summary
Keros Therapeutics, Inc. filed an 8-K on March 31, 2025, reporting on other events and financial statements. The filing details the company's corporate information, including its address in Lexington, Massachusetts, and its standard industrial classification as Pharmaceutical Preparations.
Why It Matters
This filing provides an official update on Keros Therapeutics' corporate status and financial reporting, which is crucial for investors and stakeholders to stay informed about the company's regulatory compliance and operational details.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new financial or operational information that would inherently increase risk.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- Keros Therapeutics, Inc. (company) — Registrant
- March 31, 2025 (date) — Date of Report
- Lexington, Massachusetts (location) — Principal executive offices
- 001-39264 (other) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report for Keros Therapeutics, Inc., detailing 'Other Events' and 'Financial Statements and Exhibits' as of March 31, 2025.
What is Keros Therapeutics, Inc.'s principal executive office address?
The principal executive offices of Keros Therapeutics, Inc. are located at 1050 Waltham Street, Suite 302, Lexington, Massachusetts 02421.
What is the SEC file number for Keros Therapeutics, Inc.?
The SEC file number for Keros Therapeutics, Inc. is 001-39264.
What is Keros Therapeutics, Inc.'s Standard Industrial Classification (SIC) code?
Keros Therapeutics, Inc. falls under the Standard Industrial Classification code 2834, which is for Pharmaceutical Preparations.
When is Keros Therapeutics, Inc.'s fiscal year end?
Keros Therapeutics, Inc.'s fiscal year ends on December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Keros Therapeutics, Inc. (KROS).